Celera Diagnostics, LLC, a prominent player in the biotechnology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in molecular diagnostics, focusing on innovative solutions for disease detection and management. With a strong presence in major operational regions across North America, Celera Diagnostics offers a range of core products and services, including advanced genetic testing and personalised medicine solutions. Their unique approach combines cutting-edge technology with comprehensive data analysis, setting them apart in a competitive market. Recognised for their commitment to quality and accuracy, Celera Diagnostics has achieved significant milestones, contributing to advancements in healthcare and improving patient outcomes. Their dedication to innovation positions them as a trusted partner in the evolving landscape of diagnostics.
How does Celera Diagnostics, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Celera Diagnostics, LLC's score of 31 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Celera Diagnostics, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that includes Quest Diagnostics Incorporated, from which it inherits emissions data and climate commitments. As a merged entity, Celera Diagnostics aligns its climate initiatives with those of Quest Diagnostics. However, no specific reduction targets or climate pledges have been documented for Celera Diagnostics itself. The lack of direct emissions data suggests that the company may be in the early stages of developing its own climate strategy or reporting framework. In the context of the industry, it is essential for companies like Celera Diagnostics to establish clear climate commitments and reduction targets to contribute to broader sustainability goals. The absence of specific emissions data and reduction initiatives highlights an opportunity for the company to enhance its environmental accountability and align with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 83,929,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 41,299,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 |
Celera Diagnostics, LLC's Scope 3 emissions, which decreased by 23% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 77% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 54% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Celera Diagnostics, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.